ReGen Therapeutics has acquired 2 companies.
The Company’s most targeted sectors include life science (100%).
73 Watling Street,
London,
EC4M 9BJ
United Kingdom,
44 20 7153 4920
www.regentherapeutics.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2004-10-19 |
Sciencom Ltd. · Life Science
, United Kingdom Sciencom Ltd. is a private company, which is developing an important new use for zolpidem, a long-established drug, currently marketed for the treatment of insomnia. The new use relates to a novel application of zolpidem for the treatment of ‘brain dormancy/diaschisis’ (the ‘Application’) and Sciencom has filed patent application in this regard. |
- | Add-on Acquisition | - | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
